 |
alemtuzumab |
|---|---|
| Trade Name | Campath |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1997-10-20 00:00:00 |
| Sponsor | Genzyme Corporation;4545 Horizon Hill Blvd.;San Antonio, Texas, 78229 |
| |
alemtuzumab |
|---|---|
| Trade Name | Campath |
| Orphan Indication | Chronic lymphocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1997-10-20 00:00:00 |
| Sponsor | Genzyme Corporation;4545 Horizon Hill Blvd.;San Antonio, Texas, 78229 |